Literature DB >> 119296

The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man.

V A John.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 119296

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN： 0300-3396


× No keyword cloud information.
  27 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.

Authors:  O Borgå; B Borgå
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

3.  Lack of effect of a single-dose of sulglicotide on the bioavailability of diclofenac.

Authors:  M De Bernardi di Valserra; F Feletti; F Bertè; M Nazzari; A Cenedese; U Cornelli
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.

Authors:  D J Carlile; N Hakooz; M K Bayliss; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

5.  Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.

Authors:  A Karim
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers.

Authors:  X Hui; P G Hewitt; N Poblete; H I Maibach; J Z Shainhouse; R C Wester
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

7.  A study to determine the clinical relevance of the pharmacokinetic interaction between aspirin and diclofenac.

Authors:  H A Bird; J Hill; P Leatham; V Wright
Journal:  Agents Actions       Date:  1986-06

8.  Microcapsules and transdermal patch: a comparative approach for improved delivery of antidiabetic drug.

Authors:  Manoj K Mishra; Debajyoti Ray; Bhakti B Barik
Journal:  AAPS PharmSciTech       Date:  2009-07-23       Impact factor: 3.246

9.  Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis.

Authors:  P D Fowler; M F Shadforth; P R Crook; V A John
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.